+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Depyrogenated Sterile Empty Vials Market - Global Forecast 2025-2030- Product Image
Depyrogenated Sterile Empty Vials Market - Global Forecast 2025-2030- Product Image
Sale

Depyrogenated Sterile Empty Vials Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977973
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Depyrogenated sterile empty vials play a pivotal role in pharmaceutical and biotechnology supply chains, ensuring safe, compliant delivery and storage for advanced therapeutics and diagnostics. Their importance is magnified by strict industry standards and growing biopharmaceutical innovation.

Market Snapshot: Depyrogenated Sterile Empty Vials Market

The depyrogenated sterile empty vials market grew from USD 846.93 million in 2024 to USD 907.03 million in 2025. It is expected to continue expanding at a CAGR of 6.77%, reaching USD 1.25 billion by 2030. Senior decision-makers recognize the market’s robust expansion, reflecting the strategic need for reliable, high-quality vial solutions across the life sciences sector. Growth is driven by accelerating demand for specialty packaging in biologics, vaccines, and diagnostics, as well as global shifts in regulatory expectations and manufacturing resilience.

Scope & Segmentation

  • Container Types: Glass vials (including amber and clear options) and plastic vials (with polyethylene and polypropylene choices).
  • Applications: Biotechnology (cell and gene therapy), diagnostics (clinical chemistry, immuno- and molecular diagnostics), injectables, and vaccines (COVID-19 and influenza).
  • End Users: Biotechnology firms, diagnostic laboratories (hospital-based and independent), hospitals (private and public), pharmaceutical companies (generic and innovator), and research institutes (academic and government).
  • Container Sizes: Up to 2 mL, above 2 to 5 mL, above 5 to 10 mL, and above 10 mL, supporting a range of fill-finish and bulk storage requirements.
  • Sterilization Technologies: Autoclave, ethylene oxide, and gamma radiation for flexible, compliant vial processing.
  • Geographic Coverage: Americas (including major U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East, & Africa (with key markets such as the United Kingdom, Germany, France, and Saudi Arabia), and Asia-Pacific (China, India, Japan, and more).
  • Competitive Landscape: In-depth analysis features Schott AG, Gerresheimer AG, Stevanato Group SpA, Corning Incorporated, Nipro Corporation, Piramal Glass Limited, Becton, Dickinson and Company, Nippon Electric Glass Co., Ltd., Hi-Tech Pharmaceutical Glass Co., Ltd., and Cardinal Health, Inc.

Key Takeaways for Senior Executives

  • Heightened regulatory scrutiny compels manufacturers to maintain advanced sterility controls and real-time monitoring across production.
  • Specialized vial designs and surface treatments increasingly support stability for next-generation biotherapeutics and complex diagnostics.
  • Sustainability mandates propel the adoption of recyclable polymers and energy-efficient sterilization systems, especially for heat-sensitive formats.
  • Digital traceability and quality documentation strengthen supplier-client partnerships and enable robust risk management in vial sourcing.
  • Customization capabilities help meet evolving requirements for advanced therapy projects and global vaccination programs with diverse container needs.
  • Strategic collaboration across supply chain partners, from raw material providers to end users, is facilitating design-to-cost and co-development initiatives relevant to product differentiation.

Tariff Impact and Supply Chain Resilience

Recent U.S. tariff adjustments have significantly impacted raw material sourcing, particularly in specialty glass and polymers. Manufacturers are now adopting diversified supplier networks, blending domestic and international sources to mitigate trade-related risks. This shift has driven inventory policy changes and encouraged strategic partnerships to maintain business continuity and cost controls as global trade dynamics evolve.

Methodology & Data Sources

Market insights draw from a robust blend of primary executive interviews and secondary literature, including regulatory documents, industry publications, patent filings, and trade databases. Data triangulation and expert validation processes ensure that the analyses, segmentation, and trends presented are both comprehensive and reliable.

Why This Report Matters

  • Supports actionable decision-making on supplier selection, procurement, and resilience planning in sterile vial sourcing.
  • Delivers a multi-dimensional view of market segmentation, technological adoption, and sustainability trends relevant for risk mitigation and innovation strategies.
  • Enables competitive benchmarking and identification of collaboration opportunities for capacity expansion, product innovation, or regulatory alignment.

Conclusion

As demands for quality, innovation, and supply stability intensify, depyrogenated sterile empty vials remain integral to future-ready biopharmaceutical operations. Organizations aligning technical, regulatory, and sustainability priorities will enhance their competitive positioning in this essential market segment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of single-use depyrogenated sterile empty glass vials for biologic drug delivery
5.2. Increased regulatory scrutiny driving demand for depyrogenated sterile empty vials with endotoxin testing certification
5.3. Shift toward customization of depyrogenated sterile empty vials to support personalized medicine and rare disease therapies
5.4. Integration of advanced depyrogenation technologies to enhance sterility assurance in empty vial manufacturing
5.5. Expansion of depyrogenated sterile empty vial production capacity amid global vaccine rollout and pandemic preparedness
5.6. Growing partnerships between vial manufacturers and pharmaceutical companies for turnkey depyrogenation services in clinical trials
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Depyrogenated Sterile Empty Vials Market, by Product Type
8.1. Introduction
8.2. Glass Vials
8.2.1. Amber
8.2.2. Clear
8.3. Plastic Vials
8.3.1. Polyethylene
8.3.2. Polypropylene
9. Depyrogenated Sterile Empty Vials Market, by Application
9.1. Introduction
9.2. Biotechnology
9.2.1. Cell Therapy
9.2.2. Gene Therapy
9.3. Diagnostics
9.3.1. Clinical Chemistry
9.3.2. Immunodiagnostics
9.3.3. Molecular Diagnostics
9.4. Injectables
9.5. Vaccines
9.5.1. COVID-19
9.5.2. Influenza
10. Depyrogenated Sterile Empty Vials Market, by End User
10.1. Introduction
10.2. Biotechnology Firms
10.3. Diagnostic Laboratories
10.3.1. Hospital Based Laboratories
10.3.2. Independent Laboratories
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Pharmaceutical Companies
10.5.1. Generic Manufacturers
10.5.2. Innovator Companies
10.6. Research Institutes
10.6.1. Academic Institutions
10.6.2. Government Research Centers
11. Depyrogenated Sterile Empty Vials Market, by Capacity
11.1. Introduction
11.2. Above 10 Ml
11.3. Above 2 To 5 Ml
11.4. Above 5 To 10 Ml
11.5. Up To 2 Ml
12. Depyrogenated Sterile Empty Vials Market, by Sterilization Method
12.1. Introduction
12.2. Autoclave
12.3. Ethylene Oxide
12.4. Gamma Radiation
13. Americas Depyrogenated Sterile Empty Vials Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Depyrogenated Sterile Empty Vials Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Depyrogenated Sterile Empty Vials Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Schott AG
16.3.2. Gerresheimer AG
16.3.3. Stevanato Group SpA
16.3.4. Corning Incorporated
16.3.5. Nipro Corporation
16.3.6. Piramal Glass Limited
16.3.7. Becton, Dickinson and Company
16.3.8. Nippon Electric Glass Co., Ltd.
16.3.9. Hi-Tech Pharmaceutical Glass Co., Ltd.
16.3.10. Cardinal Health, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DEPYROGENATED STERILE EMPTY VIALS MARKET: RESEARCHAI
FIGURE 26. DEPYROGENATED STERILE EMPTY VIALS MARKET: RESEARCHSTATISTICS
FIGURE 27. DEPYROGENATED STERILE EMPTY VIALS MARKET: RESEARCHCONTACTS
FIGURE 28. DEPYROGENATED STERILE EMPTY VIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AMBER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AMBER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLEAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLEAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 10 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 10 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 2 TO 5 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 2 TO 5 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 5 TO 10 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 5 TO 10 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY UP TO 2 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY UP TO 2 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AUTOCLAVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AUTOCLAVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GAMMA RADIATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GAMMA RADIATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 174. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 175. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 176. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 177. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 184. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 185. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 188. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 189. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 192. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 193. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 194. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 195. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 196. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 197. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 198. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 199. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 212. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 213. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 216. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 217. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 220. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 221. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 222. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 223. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 226. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AF

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Depyrogenated Sterile Empty Vials market report include:
  • Schott AG
  • Gerresheimer AG
  • Stevanato Group SpA
  • Corning Incorporated
  • Nipro Corporation
  • Piramal Glass Limited
  • Becton, Dickinson and Company
  • Nippon Electric Glass Co., Ltd.
  • Hi-Tech Pharmaceutical Glass Co., Ltd.
  • Cardinal Health, Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 907.03 Million
Forecasted Market Value ( USD ) by 2030 $ 1250 Million
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Depyrogenated Sterile Empty Vials Market Report 2025 - Product Image

Depyrogenated Sterile Empty Vials Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Sterile Vials - Global Strategic Business Report - Product Image

Sterile Vials - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Cyclic Olefin Polymer Vials Market - Global Forecast 2025-2030 - Product Image

Cyclic Olefin Polymer Vials Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Cryogenic Vials Market - Global Forecast 2025-2030 - Product Image

Cryogenic Vials Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 154 Pages
  • Global
From

About the Market

The Depyrogenated Sterile Empty Vials market is a subset of the Drug Discovery industry. It is a specialized market that focuses on the production of sterile, empty vials that have been depyrogenated. This process involves the removal of pyrogens, which are substances that can cause fever in humans. Depyrogenated vials are used in the production of injectable drugs, and are essential for ensuring the safety of the drug. The market is highly regulated, and manufacturers must adhere to strict quality standards. The Depyrogenated Sterile Empty Vials market is highly competitive, with many companies offering a range of products. Some of the major players in the market include West Pharmaceutical Services, Inc., Nipro Corporation, Schott AG, and Corning Incorporated. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.